Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment

被引：0
|
作者：
Ira Ekmekciu
Ulrike Fiebiger
Kerstin Stingl
Stefan Bereswill
Markus M. Heimesaat
机构：
[1] Charité-University Medicine Berlin,Department of Microbiology and Hygiene
[2] CC5,Department of Biological Safety
[3] Federal Institute for Risk Assessment (BfR),undefined
[4] National Reference Laboratory for Campylobacter,undefined
来源：
Gut Pathogens | / 9卷
关键词：
Probiotic compound; VSL#3; Secondary abiotic mice; Gnotobiotic mice; Bacterial in vivo competition; Pathogen–commensal bacteria–host interaction; Apoptosis; Innate and adaptive immune cells; Pro-inflammatory cytokines; Anti-inflammatory cytokines; Extra-intestinal and systemic sequelae of infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 48 条
  • [1] Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment
    Ekmekciu, Ira
    Fiebiger, Ulrike
    Stingl, Kerstin
    Bereswill, Stefan
    Heimesaat, Markus M.
    GUT PATHOGENS, 2017, 9
  • [2] Treatment of EAE and MS Subjects with Probiotic VSL#3
    Tankou, Stephanie
    Bailey, Kailyn
    Regev, Keren
    Kivisakk, Pia
    Ghandi, Roopali
    Kirlis, Andrew
    Cooke, Sandra
    Stuart, Fiona
    Glanz, Bonnie
    Stankiewicz, James
    Weiner, Howard
    NEUROLOGY, 2016, 86
  • [3] The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment
    Ekmekciu, Ira
    von Klitzing, Eliane
    Fiebiger, Ulrike
    Neumann, Christian
    Bacher, Petra
    Scheffold, Alexander
    Bereswill, Stefan
    Heimesaat, Markus M.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2017, 7
  • [4] VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation
    Soo, Isaac
    Madsen, Karen L.
    Teipar, Qassim
    Syclora, Beate C.
    Sherbaniuk, Richard
    Cinque, Benedetta
    Di Marzio, Luisa
    Cifone, Maria Grazia
    Desimone, Claudio
    Fedorak, Richard N.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 22 (03) : 237 - 242
  • [5] Effect of the probiotic mixture VSL#3 on inflammation and colonic permeability in a murine model of colitis
    Mennigen, R.
    Nolte, K.
    Loeffler, B.
    Rijcken, E.
    Senninger, N.
    Bruwer, M.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S36 - S36
  • [6] The probiotic mix, VSL#3, blocks a bacterial superantigen-driven murine enteropathy
    Lu, J
    De Simone, C
    McKay, D
    FASEB JOURNAL, 2005, 19 (04): : A496 - A496
  • [7] Role of a mixed probiotic product, VSL#3, in the prevention and treatment of colorectal cancer
    Wei, Lijuan
    Duan, Liwei
    Zhao, Hongyu
    Tai, Jinghua
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 930
  • [8] SUCCESSFUL USE OF PROBIOTIC VSL#3 FOR TREATMENT OF SMALL BOWEL BACTERIAL OVERGROWTH SYMPTOMS IN PEDIATRIC PATIENTS WITH INTESTINAL FAILURE
    Samela, Kate
    Bebyn, Phyllis
    Davidovics, Zev
    GASTROENTEROLOGY, 2017, 152 (05) : S626 - S626
  • [9] Effects of Probiotic VSL#3 on Cytokine and Tight Junction Protein Expression in Intestinal Epithelial Cells
    Stewart, Lauren
    Crumley, Benjamin
    Walton, Kristen
    FASEB JOURNAL, 2015, 29
  • [10] Evaluation of the efficacy of probiotic VSL#3 and synbiotic VSL#3 and yacon-based product in reducing oxidative stress and intestinal permeability in mice induced to colorectal carcinogenesis
    dos Santos Cruz, Bruna Cristina
    de Sousa Moraes, Luis Fernando
    Marcon, Leticia De Nadai
    Dias, Kelly Aparecida
    Murad, Leonardo Borges
    Sarandy, Mariaurea Matias
    da Conceicao, Lisiane Lopes
    Goncalves, Reggiani Vilela
    de Luces Fortes Ferreira, Celia Lucia
    Gouveia Peluzio, Maria do Carmo
    JOURNAL OF FOOD SCIENCE, 2021, 86 (04) : 1448 - 1462
12345